Nivolumab-Induced Fulminant Immune-Related Colitis Despite Infliximab in a Patient With NSCLC.

Autor: Callens, Rutger, Tamsin, An, van Zandweghe, Luc
Zdroj: Journal of Thoracic Oncology; Mar2019, Vol. 14 Issue 3, pe49-e50, 2p
Databáze: Complementary Index